Jalali Ghassam Behrouz, Ghaffari Hadi, Prakash H S, Kini Kukkundoor Ramachandra
Department of Studies in Biotechnology, University of Mysore , Manasagangotri, Mysore, Karnataka , India.
Pharm Biol. 2014 Aug;52(8):1060-8. doi: 10.3109/13880209.2013.877490. Epub 2014 Mar 19.
Solanum xanthocarpum Schard. and Wendl. (Solanaceae) has been used in traditional Indian medicines for its antioxidant, anti-inflammatory, and antiasthmatic properties.
The present study demonstrates the antioxidant and hepatoprotective effects of S. xanthocarpum. On the basis of in vitro antioxidant properties, the active fraction from column chromatography of the methanol extract of S. xanthocarpum leaves (SXAF) was chosen as the potent fraction and used for hepatoprotective studies in rats.
The antioxidant activity was evaluated by 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH), and reducing power assays. Rats were pre-treated with 100 and 200 mg/kg b.w. of SXAF for 14 d with a single dose of CCl4 in the last day. Hepatoprotective properties were determined by serum biochemical enzymes, aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), antioxidant enzymes (SOD, CAT, GSH, and GST), and histopathology studies.
SXAF exhibited significant antioxidant activity in scavenging free radicals with IC50 values of 11.72 µg (DPPH) and 17.99 µg (ABTS). Rats pre-treated with SXAF demonstrated significantly reduced levels of serum LDH (1.7-fold), ALP (1.6-fold), and AST (1.8-fold). Similarly, multiple dose SXAF administration at 200 mg/kg b.w. demonstrated significantly enhanced levels of SOD (1.78 ± 0.13), CAT (34.63 ± 1.98), GST (231.64 ± 14.28), and GSH (8.23 ± 0.48) in liver homogenates. Histopathological examination showed lowered liver damage in SXAF-treated groups.
These results demonstrate that SXAF possesses potent antioxidant properties as well as hepatoprotective effects against CCl4-induced hepatotoxicity.
黄果茄(茄科)因其抗氧化、抗炎和抗哮喘特性而被用于传统印度医学。
本研究证明了黄果茄的抗氧化和肝保护作用。基于体外抗氧化特性,从黄果茄叶甲醇提取物的柱色谱中获得的活性部分(SXAF)被选为有效部分,并用于大鼠的肝保护研究。
通过2,2'-联氮-双(3-乙基苯并噻唑啉-6-磺酸)(ABTS)、2,2-二苯基-1-苦基肼(DPPH)和还原力测定来评估抗氧化活性。大鼠用100和200mg/kg体重的SXAF预处理14天,最后一天给予单剂量四氯化碳。通过血清生化酶、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、碱性磷酸酶(ALP)、乳酸脱氢酶(LDH)、抗氧化酶(SOD、CAT、GSH和GST)以及组织病理学研究来确定肝保护特性。
SXAF在清除自由基方面表现出显著的抗氧化活性,DPPH的IC50值为11.72μg,ABTS的IC50值为17.99μg。用SXAF预处理的大鼠血清LDH(1.7倍)、ALP(1.6倍)和AST(1.8倍)水平显著降低。同样,以200mg/kg体重多次给予SXAF可显著提高肝匀浆中SOD(1.78±0.13)、CAT(34.63±1.98)、GST(231.64±14.28)和GSH(8.23±0.48)的水平。组织病理学检查显示SXAF治疗组的肝损伤减轻。
这些结果表明,SXAF具有强大的抗氧化特性以及对四氯化碳诱导的肝毒性的肝保护作用。